ArticleDiabetes, obesity & metabolism2025

Imeglimin and DPP-4 inhibitors: A promising therapeutic strategy for type 2 diabetes individuals with reduced insulin secretion.

Yoshiyuki Hamamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.